The percentage of patients that demonstrated either of these anomalies ranged between 5% and 50% (Figure 1C) (Cerami et al., 2012, Gao et al., 2013), demonstrating that MEAK7 genetic modifications are cancer type specific and can be observed in a diverse array of human cancers. The gene discussed is MEAK7; the disease is cancer.